Диссертация (1139920), страница 15
Текст из файла (страница 15)
Exp. Med. Biol. -2015. –Vol.803. - P.397-405.109. Heart rate variability: standards of measurement, physiologicalinterpretation and clinical use. // Task Force of the European Society of Cardiologyand the North American Society of Pacing and Electrophysiology. — Circulationю— 1996. — Vol. 93. — P. 1043-1065.110. Higgins J., Jamieson W.R., Benhameid O. et al. Influence of patient106gender on mortality after aortic valve replacement for aortic stenosis // J.
Thorac.Cardiovasc. Surg. – 2011. – Vol.142. - P.595–601.111. Hirsh J.A., Bishop В. Respiratory sinus arrhythmia in humans; howbreathing pattern modulates heart rate //Am. J. Circulation. - 1992. - Vol. 85. - P.164-171.112. Ho S.N. The role of NFAT5/TonEBP in establishing an optimalintracellular environment // Arch. Biochem. Biophys. - 2003. – Vol. 413. – P.151–157.113. Hu J., Xu X., Yang J. et al. Antihypertensive effect of taurine in rat //Adv. Exp. Med. Biol. – 2009. – Vol.643. – P.75-80.114. Huxtable R., Bressler R. Taurine concentrations in congestive heartfailure // Science.
- 1974. – Vol.184. – P.1187-1188.115. Huxtable R.J. Taurine and the heart // Cardiovasc. Res. – 1993. – Vol.27. – P.1136–1137.116. Huxtable R.J. Physiological actions of taurine // Physiol. Rev. - 1992.– Vol. 72. – P. 101-163.117. Ito T., Fujio Y., Hirata M. et al.
Expression of taurine transporter isregulated through the TonE (tonicity-responsive element)/TonEBP (TonEbindingprotein) pathway and contributes to cytoprotection in HepG2 cells // Biochem. J. 2004. – Vol. 382(Pt 1). – P.177–182.118. Ito T., Azuma J. Taurine is a possible anti-atherosclerotic agent //Nippon Yakurigaku Zasshi. – 2004. – Vol. 123(5). - P.311–317.119.
Ito T., Kimura Y., Uozumi Y. et al. Taurine depletion caused byknocking out the taurine transporter gene leads to cardiomyopathy with cardiacatrophy // J. Mol. Cell Cardiol. – 2008. – Vol. 44. - P.927-937.120. Ito T., Fujio Y., Schaffer S.W., Azuma J. Involvement oftranscriptional factor TonEBP in the regulation of the taurine transporter in thecardiomyocyte // Adv. Exp. Med Biol. - 2009.
– Vol. 643. – P. 523–532.121. Ito T., Muraoka S., Takahashi K et al. Beneficial effect of taurinetreatment against doxorubicin-induced cardiotoxicity in mice // Adv. Expt. Med.107Biol. - 2009.- Vol. 643.- P.65-73.122. Ito T., Oishi S., Takai M. et al. Cardiac and skeletal muscleabnormality in taurine transporter-knockout mice // J. Biomed Sci. - 2010.
– Vol.17 (Suppl 1). – P.20.123. Ito T., Miyazaki N., Schaffer S., Azuma J. Potential Anti-aging Roleof Taurine via Proper Protein Folding: A Study from Taurine TransporterKnockout Mouse // Adv Exp Med Biol. - 2015. – Vol.803. – P.481-487.124. Johnman C., Oldroyd K., Mackay D.
et al.: Percutaneous coronaryintervention in the elderly: changes in case-mix and periprocedural outcomes in 31,758 patients treated between 2000 and 2007 // Circ. Cardiovasc. Interv. – 2010. Vol.3 (4). - P.341–345.125. Jong C.J., Azuma J., Schaffer S.W. Role of mitochondrialpermeability transition in taurine deficiency-induced apoptosis // Exp.
Clin.Cardiol. – 2011. – Vol.16 (4). – P.125-128.126. Kamath M.V., Fallen E.L. Power spectral analysis of heart ratevariability: a noninvasive signature of cardiac autonomic function // Crit. Revs.Biomed. Engl. - 1993. - Vol. 21. - P.245-311.127. Kempson S.A., Beck J.A., Lammers P.E. et al. embrane insertion ofbetaine/GABA transporter during hypertonic stress correlates with nuclearaccumulation of TonEBP // Biochimica et Biophysica Acta. – 2005. – Vol. 1712.– P.71–80.128.
Kendler B.S. Supplemental conditionally essential nutrients incardiovascular disease therapy // J. Cardiovasc. Nurs. - 2006. – Vol.21. – P. 9–16.129.Kennergren C., Mantovani V., Lonnroth P. et al. Extracellular aminoacids as markers of myocardial ischemia during cardioplegic heart arrest //Cardiology. - 1999. – Vol. 91. - P. 31–40.130. Kilb W., Hanganu I. L., Okabe A. et al. Glycine receptors mediateexcitation of subplate neurons in neonatal rat cerebral cortex // J. Neurophysiol. 2008.
- Vol. 100, № 2. - P. 698-707.131. Kim S.J., Ramesh C., Gupta H. et al. Taurine-diabetes interaction:108from involvement to protection // J. Biol. Regul. Homeost. Agents. - 2007. - Vol.21. - P. 63-77.132. Kohashi N, Katori R. Decrease of urinary taurine in essentialhypertension // Jpn. Heart J.
– 1983. – Vol. 24. – P.91-102133. Kulthinee S., Wyss J.M., Roysommuti S. Taurine supplementationprevents the adverse effect of high sugar intake on arterial pressure control aftercardiac ischemia/reperfusion in female rats // Adv. Exp. Med. Biol. – 2015. –Vol.803. – P.597-611.134. Kuwahara M., Kawaguchi T., Ito K., Tsubone H. Effects of taurine oncardiovascular and autonomic nervous functions in cold exposed rats // Adv. Exp.Med. Biol. - 2009. – Vol. 643. – P.533-540.135. Lewis M., Littlejohns B., Hua Lin et al.
Cardiac taurine and principalamino acids in right and left ventricles of patients with either aortic valve stenosisor coronary artery disease: the importance of diabetes and gender // Springer Plus.- 2014. – Vol. 3. – P.523.136. Li F., Obrosova I. G., Abatan O. et al. Taurine replacement attenuateshyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats //AJP: Endocrinol. Metab. - 2005. - Vol. 288. - P.29-36.137. Li X. L., An Y., Jin Q.
H. et al. Changes of some amino acidconcentrations in the medial vestibular nucleus of conscious rats following acutehypotension // Neurosci. Lett. - 2010. - Vol. 477. - P. 11-14.138. Liao X.B., Zhou X.M., Li J.M. et al. Taurine transporter is expressedin vascular smooth muscle cells // Amino Acids.
– 2007. – Vol. 33(4). – P.639–643.139. Liu Y., Niu L., Zhang W. et al. Effects of taurine on contractions ofthe porcine coronary artery // Pharmacol. Rep. – 2009. – Vol.61 (4). – P.681-689.140. Lotto A.A., Ascione R., Caputo M. et al. Myocardial protection withintermittent cold blood during aortic valve operation: antegrade versus retrogradedelivery // Ann. Thorac. Surg. – 2003. - Vol.76. – P.1227–1233.141. Loyher M.L., Mutin M., Woo S.K. et al.
Transcription factor tonicity-109responsiveenhancer-bindingprotein(TonEBP)whichtransactivatesosmoprotective genes is expressed and upregulated following acute systemichypertonicity in neurons in brain // Neuroscience. - 2004. – Vol. 124. – P.89–104.142. Lubec B., Ya-hua Z., Pertti S. et al. Distribution and disappearance ofthe radiolabeled carbon derived from L-arginine and taurine in the mouse // LifeSci. – 1997.
- Vol. 60. – P.2373-2381.143. MacCormack T.J., Callaghan N.I., Sykes A.V., Driedzic W.R.Taurine depresses cardiac contractility and enhances systemic heart glucoseutilization in the cuttlefish, Sepia officinalis // J. Comp. Physiol. B. - 2016. –Vol.186 (2). – P.215-227.144. Maia A.R., Batista T.M., Victorio J.A. et al. Taurine supplementationreduces blood pressure and prevents endothelial dysfunction and oxidative stress inpost-weaning protein-restricted rats // PLoS One. – 2014.
– Vol.29;9(8):e105851.145. Matus P., Cubillos S., Lima L. Differential effect of taurine andserotonin on the outgrowth from explants or isolated cells of the retina // Int. J.Dev. Neurosci. - 2007. - Vol. 15. - P. 785-793.146. McBroom J.J., Welty J.D. Effects of taurine on heart calcium in thecardiomyopathic hamster // J. Mol. Cell Cardiol. - 1977.
– Vol.9. – P.853-858.147. McCartyM.F.Complementaryvascularprotectiveactionsofmagnesium and taurine: a rationale for magnesium taurate // Medical Hypothesis. 1996. – Vol. 46. – P. 89-100.148. Metelka R. Heart rate variability - current diagnosis of the cardiacautonomic neuropathy. A review. // Biomed Pap Med Fac Univ Palacky OlomoucCzech Repub. — 2014.
— Vol. 158. — P. 327-338.149. Militante J.D., Lombardini J.B., Schaffer S.W. The role of taurine inthe pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus //Cardiovasc. Res. - 2000. – Vol.46.- P.393-402.150.
Militante J.D., Lombardiniab J.B. Increased cardiac levels of tau- rinein cardiomyopathy: the paradoxical benefits of oral taurine treatment // Nutr. Res. 2001. – Vol.21. – P.93-102.110151. Militante J.D., Lombardini J.B. Treatment of hypertension with oraltaurine: experimental and clinical studies // Amino Acids. - 2002. – Vol. 23. –P.381- 393.152. Militante J.D., Lombardini J.B. Dietary taurine supplementa- tion:hypolipidemic and antiatherogenic effects // Nutr. Res.
- 2004. – Vol.24. – P.787801.153. Modi P., Suleiman M.S., Reeves B.C. et al. Free amino acids in heartsof pediatric patients with congenital heart disease: the effects of cyanosis, age, andpathology // Ann. Thorac. Surg. - 2006. – Vol. 81. – P. 943–949.154. Moloney M.A., Casey R.G., O'Donnell D.H. et al. Two weeks taurinesupplementation reverses endothelial dysfunction in young male type 1 diabetics //Diab. Vasc. Dis.
Res. - 2010. – Vol. 7. – P.300-310.155. Nagai K., Fukuno S., Oda A., Konishi H. Protective effectsof taurine on doxorubicin-induced acute hepatotoxicity through suppression ofoxidative stress and apoptotic responses // Anticancer Drugs. – 2016. – Vol.27 (1).– P.17-23.156. Nagy L., Morales R. E., Beinborn M. et al. Investigation ofgastroprotective compounds at subcellular level in isolated gastric mucosal cells //AJP: Gastrointest.
Liver Physiol. - 2009. - Vol. 270. - P. 1201-1208.157. Nandhini А.Т., Thirunavukkarasu V., Ravichandran M.K., AnuradhaC.V. Effect of taurine on biomarkers of oxidative stress in tissues of fructose-fedinsulin-resistant rats // Singapore Med. J. - 2011. – Vol.46(2). - P. 82–87.158. Nevoia A. Modificarile continutului aminoacizilor liberi la §obolaniide diferita varsta la actiunea factorilor stresogeni de diversa natura // Teza doct. inbiolodie.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
